HUTCHMED Highlights Presentation of Phase III Data on : vimarsana.com

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)...

Related Keywords

Japan , Shanghai , China , Australia , United States , Panmure , Victoria , Hong Kong , American , Atholl Tweedie , Ben Atwell Alex Shaw , Daphne Zhang , Freddy Crossley , Zhou Yi , Rui Hua Xu , American Society Of Clinical Oncology , Nasdaq , China Limited , Stock Exchange Of Hong Kong , Exchange Commission , Linkedin , China National Reimbursement Drug List , Journal Of The American Medical Association , American Society , Clinical Oncology , Plenary Series Session , New Drug Application , China National Medical Products Administration , Fruquintinib Approval , American Medical Association , Securities Litigation Reform Act , Stock Exchange , Alex Shaw , Global Cancer Observatory , Stomach Cancer Fact , Accessed April , China Fact , Nasdaq Hcm , Utchmed China Limited ,